News Releases

Oculos and Optceutics Partner to Bring Expanded Services to Ophthalmic Innovators

Combined expertise and experience broadens the services offered by both companies to clients in a seamless manner – from Concept to Commercialization APRIL 26, 2019 – Rush, New York and London, UK – Oculos (www.OculosCR.com), an industry-leading vertically-integrated ophthalmic R&D organization, and Optceutics (www.optceutics.com), a leading expert in ophthalmic R&D and the developer of the […]

Genetic Toxicologist Raymond Proudlock Joins iuvo BioScience Extended Team

April 15, 2019 – Rochester, NY – iuvo BioScience is proud to introduce Ray Proudlock as a member of our iuvo BioScience extended team.  Ray will oversee iuvo BioScience’s Genetic Toxicology laboratory.  He is a world-renowned scientist and brings a deep scientific expertise in genetic toxicology and a wealth of experience from leadership roles in […]

iuvo Attending ARVO 2019, April 28 – May 2

March 25, 2019 – iuvo BioScience and Oculos will be attending the ARVO (The Association for Research in Vision and Ophthalmology) 2019 Annual Meeting in Vancouver, British Columbia, Canada from April 28 through May 2 at the Vancouver Convention Centre.   Both the preclinical and clinical research teams will be represented at the meeting, and we’d be […]

iuvo Attending SOT ToxExpo, March 10-14, 2019

March 4, 2019 – iuvo BioScience will be attending the 58th Annual Meeting and ToxExpo for the Society of Toxicology, March 10-14, 2019. The meeting will be held at the Baltimore Convention Center at 1 West Pratt Street, Baltimore, Maryland.  To register for the meeting, visit the SOT website here. iuvo will be represented by […]

iuvo BioScience and Oculos Clinical Research Announce Key Hires

September 18, 2018 – Rochester, NY and Tampa, FL – iuvo BioScience is proud to announce, in support of the continued growth of the business, the following professionals joining the organization.   Ronil Patel – Business Development Executive Ronil has joined the Oculos Clinical Research team as a Business Development Executive.  Ronil brings over a […]

iuvo BioScience, Industry-Leading Pre-Clinical Research Organization, Acquires Oculos Clinical Research

Combined expertise and experience creates fully integrated, research to release, ophthalmic development services company. July 9, 2018 – Rush, New York and Tampa, Florida – iuvo BioScience, an industry leading R&D services company specializing in safety, microbiology, toxicology, and analytical chemistry testing for the medical device and pharmaceutical industries, announced today that it has added […]

iuvo Completes Four Successful Regulatory Inspections

June 29, 2018 – RUSH, NY – iuvo BioScience is proud to announce that, in a span of two weeks, the company hosted and passed re-accreditation inspections from the following agencies and for the following standards:     US Department of Agriculture Annual Inspection ISO 17025:2017 reaccreditation audit ISO 13485:2016 surveillance audit AAALAC accreditation audit […]

iuvo CSO Mary Richardson Receives United Way Shining Star Award

June 12, 2018 – As iuvo recently wrapped up its 2018 United Way Campaign, iuvo’s Chief Scientific Officer Mary Richardson received a Shining Star award from the United Way of Greater Rochester in recognition for her commitment and leadership to this program.  The Shining Star award recognizes consistent high performing senior champions and coordinators who […]

Dr. Mary Richardson Presenting at PQRI Extractables and Leachables Workshop

April 16, 2018 – iuvo BioScience’s Chief Scientific Officer Dr. Mary Richardson will be presenting on ophthalmic drug products considerations for E&L studies at the Product Quality Research Institute Extractables and Leachables Workshop this week. The PQRI PODP Extractables and Leachables Workshop takes place April 18-19, 2018 at the USP Meeting Center in Rockville, Maryland.  […]

iuvo Attending Ophthalmology Innovation Summit, April 12, 2018

April 9, 2018 – Iuvo BioScience will be attending the Ophthalmology Innovation Summit (OIS) on April 12, 2018 at The Renaissance Washington, in Washington, DC.  Ben Burton, iuvo’s CEO, will be in attendance.  The OIS was designed to unite industry, entrepreneurs and clinical thought leaders to collaborate on the development and commercialization of innovative drugs […]